|Articles|May 26, 2010

Agilent completes Varian acquisition

Agilent Technologies has announced the completion of its acquisition of scientific-equipment maker Varian. The deal was reported to have cost Agilent approximately $1.5 billion in cash.

Agilent Technologies has announced the completion of its acquisition of scientific-equipment maker Varian. The deal was reported to have cost Agilent approximately $1.5 billion in cash.

In a statement from the company, Bill Sullivan, president and CEO said "The Varian acquisition - the largest in our company's history - furthers our evolution toward becoming a global leader in bio-analytical measurement. We're gaining tremendous talent and technology. And for our customers, this will mean a broader span of expertise, applications and products from one trusted company."

The majority of Varian's product lines will report into Agilent's Chemical Analysis Group (CAG), while some key businesses will be housed within Agilent's Life Sciences Group (LSG).

"Varian's products and applications expertise complement our offerings by providing a more complete spectroscopy, consumables and services portfolio to our customers," added Mike McMullen, Agilent senior vice president and president of CAG.

For more information visit www.agilent.com


Related to this article

LC-MS/MS Method Detects Propofol via Metabolite
Koji Yamaguchi of the International University of Health and Welfare (Narita, Japan) discusses a novel derivatized liquid chromatography-tandem mass spectrometry (LC-MS/MS) method plus propofol glucuronide (PRG) marker which improves forensic propofol detection.